Yahoo Finance Results
- Reuters via Yahoo FinanceAug 02 20:43 PM
In a lawsuit filed in federal court in Cleveland, Ohio, Allergan said the "primary basis" for the claims against it was the alleged improper marketing and sale of Kadian, a form of morphine, ...
The Justice Association Claims to Have Additional Information Available Regarding Lawsuit Against Opioid Pharmaceutical CompaniesMarket Watch1 day ago
- Dallas Morning News2 days ago
- KATC 3 Lafayette3 days ago
- Reuters via Yahoo FinanceAug 02 20:10 PM
In a lawsuit filed in federal court in Cleveland, Ohio, Allergan said the "primary basis" for the claims against it was the alleged improper marketing and sale of Kadian, form of morphine, in ...
- Zacks via Yahoo FinanceAug 02 13:19 PM
In early Aug 2016, Teva acquired Allergan’s generics business – Actavis Generics and in Oct 2016 it acquired the latter’s Anda Inc., the 4th largest distributor of generic pharmaceuticals ...
- Zacks via Yahoo FinanceAug 03 15:22 PM
Teva Pharmaceutical Industries Limited TEVA reported second-quarter 2018 earnings of 78 cents per share, which beat the Zacks Consensus Estimate of 67 cents per share. Sales continue to be hurt ...
Washington County Joins the Fight Against the Opioid Industry: Lawsuit Alleges Defendants' Illegal Practices Devastated SW Virginia CountyPR Newswire via Yahoo FinanceAug 06 16:45 PM
Washington County, Virginia, represented by Sanford Heisler Sharp, LLP, Kaufman & Canoles, P.C., and The Cicala Law Firm PLLC today initiated legal action against opioid manufacturers, distributors ...
- Thomson Reuters StreetEvents via Yahoo FinanceAug 02 17:24 PM
In the North American generic marketplace, we saw that revenues in the second quarter of '18 compared to the second quarter of '17 were down, and you would say, the 2 main reasons were the competition ...
- Thomson Reuters StreetEvents via Yahoo FinanceAug 14 19:40 PM
In the second quarter on an adjusted basis the Generics business achieved 7% top line sequential growth as we capitalized on 16 product launches during the first 6 months of 2018. This included ...
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Actavis Generics (formerly known as Watson Pharmaceuticals and Actavis PLC, prior to the acquisition of Allergan Inc) is a global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
Allergan, Inc. and Actavis, Inc. Stock Drop Challenge Blames Fiduciaries for Losses
PARSIPPANY, N.J., Jan. 24, 2013 /PRNewswire/ -- Watson Pharmaceuticals, Inc. today announced that the company has adopted Actavis, Inc. (NYSE: ACT) as its new global name and will today begin trading under a new symbol — ACT — on the New York Stock Exchange. The company first announced its ...
Actavis Pharma, Inc. company research & investing information. Find executives and the latest company news.
FTC v. Actavis, Inc., 570 U.S. ___, 133 S. Ct. 2223 (2013), was a United States Supreme Court decision in which the Court held that the FTC could make an antitrust challenge under the rule of reason against a so-called pay-for-delay agreement, also referred to as a reverse payment patent settlement.
Actavis, Inc. was a global pharmaceutical company that was involved in the development, manufacture, and distribution of its own brand named pharmaceuticals as well as the manufacture and distribution of generic pharmaceutical products, particularly a number of generic products from a company it had acquired, Watson Pharmaceuticals.
- related to Actavis, Inc